Eli Lilly will pay up to $1.3bn for Superluminal Medicines to discover and progress small-molecule therapeutics for GPCR ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...

Texas is seeking more than $1 million from Eli Lilly in a lawsuit accusing the drugmaker of persuading physicians to prescribe its medications, including GLP-1s such as Mounjaro and Zepbound, through ...

The latest obesity bet from Eli Lilly and Co. involves a Boston biotech based out of the pharma giant’s new Fort Point R&D ...

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy ...

Texas Pacific Land Corporation ( TPL) shares rose after the owner of properties for oil and gas exploration announced it was ...

Eli Lilly is significantly increasing the UK list price of its weight-loss and diabetes drug, Mounjaro, by up to 170%. This ...

Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330.

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

Chinese authorities did not renew a conditional approval of Green Valley Pharmaceuticals’ controversial Alzheimer’s disease ...